A detailed history of Vestal Point Capital, LP transactions in Insmed Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 750,000 shares of INSM stock, worth $51.1 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares
750,000
Previous 750,000 -0.0%
Holding current value
$51.1 Million
Previous $20.3 Billion 146.96%
% of portfolio
3.75%
Previous 1.68%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.72 - $29.94 $3.86 Million - $4.49 Million
-150,000 Reduced 16.67%
750,000 $20.3 Billion
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $21.1 Million - $28.6 Million
900,000 New
900,000 $27.9 Billion

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.22B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.